Zhejiang Gongdong Medical Technology Co.Ltd(605369) 4 on April 17, the annual report of 2021 was released. The annual operating revenue of the company exceeded 1 billion yuan for the first time, reaching 11942542 million yuan, with a year-on-year increase of 43.95%; The net profit attributable to the shareholders of the listed company was 3109872 million yuan, a year-on-year increase of 37.68%; The net profit attributable to the owners of the parent company after deducting non recurring profits and losses was 296068300 yuan, a year-on-year increase of 37.68%; The company achieved record high operating income, net profit, total assets and net assets.
Zhejiang Gongdong Medical Technology Co.Ltd(605369) its main business is the R & D, production and sales of disposable medical consumables. After more than 30 years of development, the company has continuously expanded the depth and breadth of its product line. At present, it has become an enterprise with complete product types and large scale among China’s disposable medical consumables manufacturers.
Drive development with innovation and build differentiated competitiveness. As a high-tech enterprise, Zhejiang Gongdong Medical Technology Co.Ltd(605369) has always attached importance to product R & D and technological innovation, continuously improved production technology and process level, and established a perfect quality control system. The company has passed ISO13485 quality management system certification, and “laboratory and medical consumables” have been recognized as Zhejiang famous brand products by Zhejiang Provincial Bureau of quality and technical supervision. Many products have passed the EU CE certification, and the disposable sterile vaginal dilator and sharp instrument collection barrel products have obtained the fda510 (k) license of the United States. At the same time, the company has always paid attention to the construction of intellectual property protection system and quality management system, introduced ISO9000, ISO13485, FDA and other production quality management system requirements into the company’s quality management system, and has a mature medical device production system and certification from global mainstream countries. During the reporting period, the company obtained 11 new utility model patents and 1 appearance patent; Newly obtained one China class II medical device registration certificate and one China class I medical device Filing Certificate.
The consumption demand of medical devices and consumables industry has certain regionality, which is mainly affected by the level of economic development, population density, residents’ income and the distribution of medical institutions. In 2021, China’s epidemic prevention and control entered a normal state, Zhejiang Gongdong Medical Technology Co.Ltd(605369) adjusted the existing sales business structure and internal operation management system accordingly, split the domestic business department into three independent sales departments: “medical end business”, “IVD supporting business” and “pharmaceutical enterprise business”, and re integrated the existing sales team and sales resources according to the new business management system. In addition, the company began to layout consumables products in the scientific research field, further improve the company’s product camp, and add new impetus to the company’s future performance growth.
With high-quality products and services, Zhejiang Gongdong Medical Technology Co.Ltd(605369) has been widely recognized by customers at home and abroad. The products cover most provinces and cities in China and are sold to many countries and regions in North America, Asia, South America, Africa and Europe. During the reporting period, the company’s main business income from domestic sales reached 770349600 yuan, a year-on-year increase of 85.30%; The main business income from overseas sales was 4180591 million yuan, a year-on-year increase of 3.54%.
